Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-03

FDA Approved: DECITABINE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approves a supplemental ANDA for Dr. Reddy's Laboratories Inc. to market a generic decitabine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)